Kingfisher Cooperative, LLC
Spokane, Washington, United States
Medical office in Spokane, Washington
26 E 5th Ave, Spokane, WA 99202
About Kingfisher Cooperative, LLC
"Kingfisher TMS is a leading provider of Transcranial Magnetic Stimulation (TMS), a non-pharmacological, non-invasive FDA-approved therapy for treatment-resistent depression. TMS is covered by most insurance companies."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Biogen
4
Allergan
1
AriBio Co., Ltd.
1
Eisai Inc.
1
Eli Lilly and Company
1
TauRx Therapeutics Ltd
1
University of Southern California
1
Clinical Trials at Kingfisher Cooperative, LLC
During the past decade, Kingfisher Cooperative, LLC conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 2 clinical trials were completed, i.e. on
average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy, Safety, and Tolerability of Multiple Dosing Regimens of Oral Atogepant (AGN-241689) in Episodic Migraine Prevention
2016-09-06
2018-04-23
Completed
834
Safety and Efficacy of TRx0237 in Subjects With Alzheimer's Disease Followed by Open-Label Treatment
2018-01-10
2023-03-01
Active, not recruiting
598
Efficacy and Safety of 26-Week Treatment of AR1001 in Patients With Mild to Moderate Alzheimer's Disease
2019-04-01
2021-06-28
Completed
210
A Study of Aducanumab in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease or With Mild Alzheimer's Disease Dementia to Evaluate the Safety of Continued Dosing in Participants With Asymptomatic Amyloid-Related Imaging Abnormalities
2018-12-20
2019-07-30
Terminated
52
A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease
2019-03-27
2027-09-15
Active, not recruiting
1,906
A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205
2020-03-02
2025-02-03
Active, not recruiting
1,696
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
2020-06-19
2025-08-22
Active, not recruiting
1,800
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Kingfisher Cooperative, LLC" #1 sponsor was "Biogen" with 4 trials, followed by "Allergan" with 1 trials
sponsored, "AriBio Co., Ltd." with 1 trials sponsored, "Eisai Inc." with 1 trials sponsored and "Eli Lilly and Company"
with 1 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Kingfisher Cooperative, LLC"
#1 collaborator was "Alzheimer's Therapeutic Research Institute" with 1 trials as a collaborator, "Biogen" with 1 trials as a collaborator, "National Institute on Aging (NIA)" with 1 trials as a collaborator and "Vanderbilt University" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Kingfisher Cooperative, LLC
According to Clinical.Site data, the most researched conditions in "Kingfisher Cooperative, LLC" are
"Alzheimer's Disease" (3 trials), "Alzheimer Disease" (2 trials), "Alzheimer's Disease Dementia" (1 trials), "Cognitive Dysfunction" (1 trials) and "Early Alzheimer's Disease" (1 trials). Many other conditions were trialed in "Kingfisher Cooperative, LLC" in a lesser frequency.
Clinical Trials Intervention Types at Kingfisher Cooperative, LLC
Most popular intervention types in "Kingfisher Cooperative, LLC" are "Drug" (10 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "Aducanumab" (3 trials), "AR1001" (1 trials), "Atogepant" (1 trials) and "BIIB080" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Kingfisher Cooperative, LLC
The vast majority of trials in "Kingfisher Cooperative, LLC" are
10 trials for "All" genders.
Clinical Trials Status at Kingfisher Cooperative, LLC
Currently, there are NaN active trials in "Kingfisher Cooperative, LLC".
undefined are not yet recruiting,
3 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Kingfisher Cooperative, LLC,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Kingfisher Cooperative, LLC, 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".